EUVIMEDOpdag EUVIMED
ValidierungsstudieOpen access

Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma

Ryan Yanzhe Lim, Vigneshwaran Selvakumar, Nicholas Syn, Gang Chen iD, Jie Li iD, Zin Myint Kyaw, Juequn Zhou, Beom Kyung Kim, Karn Wijarnpreecha, Hirokazu Takahashi iD, Daniel Q Huang iD, Liver Cancer Research Network

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 930-939

DOI: 10.1111/apt.70797 ↗

At a glance

Validierungsstudie in Alimentary Pharmacology & Therapeutics, published online on 2026-06-18. Written by Ryan Yanzhe Lim and 11 co-authors. Institution: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Machine Learning. Cited 4 times so far (Crossref); 33 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Prognostic models for hepatocellular carcinoma (HCC) may have limited accuracy. We aimed to construct and validate a novel prognostic model for HCC that incorporates biomarkers for liver function and tumour characteristics.

Methods

Consecutive participants ( n = 1102) with HCC from five international tertiary institutions in Asia and the U.S. comprised the derivation ( n = 627), internal validation ( n = 270) and external validation ( n = 205) cohorts. The Liver Cancer Risk predictioN (LCRN) Index was constructed using a gradient‐boosted decision tree model based on the Cox proportional hazards framework. The discriminative performance of the LCRN Index was evaluated using Harrell's concordance index (C‐index) and compared to the albumin bilirubin grade (ALBI), Barcelona Clinic for Liver Cancer (BCLC) staging and Cox regression model. Model calibration was assessed using the integrated Brier score and calibration plots.

Results

The median (IQR) age was 66.0 (58.0–73.0) years, median (IQR) body mass index was 23.9 (22.1–26.1) kg/m 2 and 77.2% were male. The LCRN Index comprised type 2 diabetes mellitus, ascites, hepatic encephalopathy, albumin, bilirubin, AFP and diameter of largest tumour nodule. In the external validation cohort, the LCRN Index (1‐year area under the receiver operating curve [AUC]: 0.79; 3‐year AUC: 0.77; 5‐year AUC: 0.75) was numerically higher than the ALBI grade and BCLC stage for prognosticating HCC. The LCRN Index demonstrated improved calibration compared to the ALBI grade and BCLC stage.

Conclusion

The LCRN index is a promising tool for prognosticating HCC. If further validated, these data may have potential clinical implications for the management of HCC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMachine LearningHumansMalePrognosisFemaleMiddle AgedAgedPredictive Learning ModelsProportional Hazards Models

Author keywords

liver cancermachine learning modelprognostic systems

Authors and institutions

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • National University of Singapore, Department of Biomedical Informatics, Yong Loo Lin School of Medicine, Singapore, Singapore.
  • National University of Singapore, Department of Pathology, Yong Loo Lin School of Medicine, Singapore, Singapore.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
  • Zhejiang-Germany Interdisciplinary Joint Laboratory of Hepatobiliary-Pancreatic Tumor and Bioengineering, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.

ORCID profiles: Gang Chen, Jie Li, Hirokazu Takahashi, Daniel Q Huang

Cite

APA

Lim, R. Y., Selvakumar, V., Syn, N., Chen, G., Li, J., Kyaw, Z. M., Zhou, J., Kim, B. K., Wijarnpreecha, K., Takahashi, H., Huang, D. Q., & Liver Cancer Research Network (2026). Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics, 64(7), 930-939. https://doi.org/10.1111/apt.70797

Vancouver

Lim RY, Selvakumar V, Syn N, Chen G, Li J, Kyaw ZM, et al. Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 2026;64(7):930-939. doi:10.1111/apt.70797

BibTeX
@article{Lim2026,
  author = {Lim, Ryan Yanzhe and Selvakumar, Vigneshwaran and Syn, Nicholas and Chen, Gang and Li, Jie and Kyaw, Zin Myint and Zhou, Juequn and Kim, Beom Kyung and Wijarnpreecha, Karn and Takahashi, Hirokazu and Huang, Daniel Q and Liver Cancer Research Network, Liver Cancer Research Network},
  title = {Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {930--939},
  doi = {10.1111/apt.70797}
}
Start for free →